Michael Wuczkowski
Life Sciences Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Wuczkowski.
Microbiological Research | 2003
Michael Wuczkowski; Irina S. Druzhinina; Youssuf Gherbawy; Brigitte Klug; Hansjörg Prillinger; Christian P. Kubicek
We investigated the occurrence and genetic diversity of Trichoderma in the river Danube national park, a primeval, riparian forest area located south-east of Vienna (Austria) which represents one of the last cases of an original European river-floodplain landscape. Forty-six strains were isolated and identified at the species level by analysis of morphological characters, by sequence analysis of their internal transcribed spacer regions 1 and 2 (ITS 1 and 2) of the rDNA cluster and--in some cases--a fragment of the translation elongation factor 1alpha (tef1) gene, and RAPD-analysis. Twenty-one strains were positively identified as T. harzianum, thirteen as T. rossicum, four as T. cerinum, two as T. hamatum, and one each as T. atroviride and T. koningii: four strains yielded two different ITS1 and 2 as well as tef1 sequence types, which were not alignable with any known species. Our studies show that they represent two new taxa of Trichoderma.
International Journal of Systematic and Evolutionary Microbiology | 2011
Michael Wuczkowski; Volkmar Passoth; Benedetta Turchetti; Ann-Christin Andersson; Matilda Olstorpe; Arja Laitila; Bart Theelen; María van Broock; Pietro Buzzini; Hansjörg Prillinger; Katja Sterflinger; Johan Schnürer; Teun Boekhout; Diego Libkind
The novel genus Holtermanniella is proposed here to accommodate four Cryptococcus species closely related to Holtermannia corniformis that are included in the Holtermannia clade (Basidiomycota, Agaricomycotina). Thus, four novel combinations are proposed: Holtermanniella nyarrowii comb. nov., Holtermanniella festucosa comb. nov., Holtermanniella mycelialis comb. nov. and Holtermanniella wattica comb. nov. In addition, a novel anamorphic yeast species was studied with 15 isolates obtained from different habitats around the world. Analysis of the sequences of the D1/D2 region of their large subunit rDNA showed that the novel species is placed phylogenetically within the Holtermannia clade of the Tremellomycetes (Agaricomycotina, Basidiomycota). PCR fingerprinting and sequencing of ITS1-5.8S-ITS2 showed genetic intraspecific variability among the strains: three groups were formed, which did not correlate with geographical origin or substrate. This novel species, designated the type species of Holtermanniella gen. nov., is described as Holtermanniella takashimae sp. nov.; the type strain is CBS 11174(T) (=HB 982(T) =DBVPG 8012(T)). The order Holtermanniales ord. nov. is proposed here to include Holtermannia (the type genus) and Holtermanniella.
Mycological Progress | 2008
Orsolya Molnár; Michael Wuczkowski; Hansjörg Prillinger
The yeast biodiversity in the guts of several pests (Diabrotica virgifera, Helicoverpa armigera, Ostrinia nubilalis) on maize from two isolation sources was assessed by cultivation-dependent and cultivation-independent methods. These yeasts are considered to bear a potentially high biotechnological relevance due to their potential ability to degrade several mycotoxins incorporated by their hosts. The 97 isolated yeast strains showed 21 different partial sequence types of the 26S rRNA gene which could be assigned to 10 different genera. The determined genera and species are discussed in terms of the meaning of their taxonomic status or their occurrence in nature. Two cultivation-independent methods, cloning and DGGE, were compared. We propose the combination of these methods as well as the combination of both cultivation-independent and cultivation-dependent approaches, for gaining better insights into fungal biodiversity.
International Journal of Cancer | 2015
Daniel Veigel; Renate Wagner; Gerald Stübiger; Michael Wuczkowski; Martin Filipits; Reinhard Horvat; Bellinda Benhamú; María L. López-Rodríguez; Asha Leisser; Peter Valent; Michael Grusch; Fausto G. Hegardt; Jordi Garcia; Dolors Serra; Nelly Auersperg; Ramon Colomer; Thomas W. Grunt
Ovarian cancer (OC) is caused by genetic aberrations in networks that control growth and survival. Importantly, aberrant cancer metabolism interacts with oncogenic signaling providing additional drug targets. Tumors overexpress the lipogenic enzyme fatty acid synthase (FASN) and are inhibited by FASN blockers, whereas normal cells are FASN‐negative and FASN‐inhibitor‐resistant. Here, we demonstrate that this holds true when ovarian/oviductal cells reside in their autochthonous tissues, whereas in culture they express FASN and are FASN‐inhibitor‐sensitive. Upon subculture, nonmalignant cells cease growth, express senescence‐associated β‐galactosidase, lose FASN and become FASN‐inhibitor‐resistant. Immortalized ovarian/oviductal epithelial cell lines—although resisting senescence—reveal distinct growth activities, which correlate with FASN levels and FASN drug sensitivities. Accordingly, ectopic FASN stimulates growth in these cells. Moreover, FASN levels and lipogenic activities affect cellular lipid composition as demonstrated by thin‐layer chromatography. Correlation between proliferation and FASN levels was finally evaluated in cancer cells such as HOC‐7, which contain subclones with variable differentiation/senescence and corresponding FASN expression/FASN drug sensitivity. Interestingly, senescent phenotypes can be induced in parental HOC‐7 by differentiating agents. In OC cells, FASN drugs induce cell cycle blockade in S and/or G2/M and stimulate apoptosis, whereas in normal cells they only cause cell cycle deceleration without apoptosis. Thus, normal cells, although growth‐inhibited, may survive and recover from FASN blockade, whereas malignant cells get extinguished. FASN expression and FASN drug sensitivity are directly linked to cell growth and correlate with transformation/differentiation/senescence only indirectly. FASN is therefore a metabolic marker of cell proliferation rather than a marker of malignancy and is a useful target for future drug development.
Oncotarget | 2017
Renate Wagner; Gerald Stübiger; Daniel Veigel; Michael Wuczkowski; Peter Lanzerstorfer; Julian Weghuber; Emmanouil Karteris; Karin Nowikovsky; Nastasia Wilfinger-Lutz; Christian F. Singer; Ramon Colomer; Bellinda Benhamú; María L. López-Rodríguez; Peter Valent; Thomas W. Grunt
Receptor-PI3K-mTORC1 signaling and fatty acid synthase (FASN)-regulated lipid biosynthesis harbor numerous drug targets and are molecularly connected. We hypothesize that unraveling the mechanisms of pathway cross-talk will be useful for designing novel co-targeting strategies for ovarian cancer (OC). The impact of receptor-PI3K-mTORC1 onto FASN is already well-characterized. However, reverse actions–from FASN towards receptor-PI3K-mTORC1–are still elusive. We show that FASN-blockade impairs receptor-PI3K-mTORC1 signaling at multiple levels. Thin-layer chromatography and MALDI-MS/MS reveals that FASN-inhibitors (C75, G28UCM) augment polyunsaturated fatty acids and diminish signaling lipids diacylglycerol (DAG) and phosphatidylinositol 3,4,5-trisphosphate (PIP3) in OC cells (SKOV3, OVCAR-3, A2780, HOC-7). Western blotting and micropatterning demonstrate that FASN-blockers impair phosphorylation/expression of EGF-receptor/ERBB/HER and decrease GRB2–EGF-receptor recruitment leading to PI3K-AKT suppression. FASN-inhibitors activate stress response-genes HIF-1α-REDD1 (RTP801/DIG2/DDIT4) and AMPKα causing mTORC1- and S6-repression. We conclude that FASN-inhibitor-mediated blockade of receptor-PI3K-mTORC1 occurs due to a number of distinct but cooperating processes. Moreover, decrease of PI3K-mTORC1 abolishes cross-repression of MEK-ERK causing ERK activation. Consequently, the MEK-inhibitor selumetinib/AZD6244, in contrast to the PI3K/mTOR-inhibitor dactolisib/NVP-BEZ235, increases growth inhibition when given together with a FASN-blocker. We are the first to provide deep insight on how FASN-inhibition blocks ERBB-PI3K-mTORC1 activity at multiple molecular levels. Moreover, our data encourage therapeutic approaches using FASN-antagonists together with MEK-ERK-inhibitors.
Mycological Progress | 2009
Hansjörg Prillinger; Michael Wuczkowski; Ksenija Lopandic; Robert Bauer; Orsolya Molnár; Katja Sterflinger
Based on DNA-fingerprinting, ITS-DNA sequencing and physiological characteristics, a new species of Schizonella, Sch. caricis-atratae, is described. Sch. caricis-atratae is a so-called cryptic species, i.e. morphologically it is identical to Sch. melanogramma, but differs in physiological and molecular phylogenetic characters. Sch. caricis-atratae can be distinguished by the following tests: growth on myo-inositol, D,L-lactate, salicine, maltose, αmethyl-D-glucoside, butane-2,3-diol, and D-turanose, at 30°C; no growth on galactose. Sch. caricis-atratae can be isolated from Carex atrata. The type strain is HB 3, CBS 123477.
Journal of Microbiological Methods | 2016
Gerald Stübiger; Michael Wuczkowski; Luis Mancera; Ksenija Lopandic; Katja Sterflinger; Omar Belgacem
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) becomes the method of choice for the rapid identification of microorganisms (i.e. protein biotyping). Although bacterial identification is already quite advanced, biotyping of other microbes including yeasts and fungi are still under development. In this context, lipids (e.g. membrane phospholipids) represent a very important group of molecules with essential functions for cell survival and adaptation to specific environments and habitats of the microorganisms. Therefore, lipids show the potential to serve as additional molecular parameters to be used for biotyping purposes. In this paper we present a molecular characterisation of yeasts and filamentous fungi based on the analysis of lipid composition by MALDI-MS (i.e. MALDI lipid phenotyping). Using a combination of Principal Component Analysis (PCA) and Hierarchical Clustering we could demonstrate that this approach allowed a classification and differentiation of several groups of yeasts (e.g. Saccharomyces) and filamentous fungi (e.g. Aspergillus, Penicillium, Trichoderma) at the species/strain level. By analysing the MALDI lipid profiles we were able to differentiate 26 closely related yeast strains, for which discrimination via genotypic methods like AFLP in this case are relatively more elaborate. Moreover, employing statistical analysis we could identify those lipid parameters (e.g. PCs and LPCs), which were responsible for the differentiation of the strains, thus providing insights into the molecular basis of our results. In summary, MALDI lipid phenotyping represents a suitable method for fungal characterization and shows the potential to be used as companion tool to genotyping and/or protein biotyping for the characterization and identification of yeasts and fungi in diverse areas (e.g. environmental, pharmaceutical, clinical applications, etc.).
The Yeasts (Fifth Edition) | 2010
Ksenija Lopandic; Hansjörg Prillinger; Michael Wuczkowski
Publisher Summary This chapter studies the genus Fellomyces. In the determination of the asexual reproduction it is seen that cells are spherical or ellipsoidal and reproduce by enteroblastic budding and by formation of blastoconidia on stalk-like conidiophores. The blastoconidia are freed by an end-break in the stalk-like conidiophores without forceful ejection. True hyphae may or may not be produced. Ballistoconidia are not formed. Sexual reproduction is unknown. The chapter also discusses physiology/biochemistry and phylogenetic placement of the genus. The type species taken is Fellomyces polyborus. The key characters of species assigned to the genus Fellomyces are also discussed. In the systematic discussion of the species, growth on malt extract agar, growth in malt extract, Dalmau plate culture on corn meal agar, gene sequence accession numbers, type strain, origin of the strains studied, and systematics are determined.
Microbiological Research | 2004
Michael Wuczkowski; Hansjörg Prillinger
International Journal of Systematic and Evolutionary Microbiology | 2010
Michael Wuczkowski; Volkmar Passoth; Benedetta Turchetti; Sandra Andersson; Matilda Olstorpe; Aarno Laitila; Bart Theelen; María van Broock; Pietro Buzzini; Hansjörg Prillinger; Katja Sterflinger; Johan Schnürer; Teun Boekhout; Diego Libkind